课题基金 / 基金详情

Establishment of evaluating system for the efficacy of the prostate cancer gene therapy using orthotopic mouse tumor model

Establishment of evaluating system for the efficacy of the prostate cancer gene therapy using orthotopic mouse tumor model
原位小鼠肿瘤模型前列腺癌基因治疗疗效评价体系的建立
批准号:
11671556
负责人:
NASU Yasutomo
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

NASU Yasutomo的其他基金

相似基金

相关文献

中文摘要
翻译
小鼠原位前列腺肿瘤模型是一种理想的模拟前列腺解剖生物学环境的临床前动物模型。与皮下肿瘤模型相比,该模型唯一的缺点是难以按时间顺序监测肿瘤生长情况。我们将经直肠超声技术(TRUS)应用于小鼠原位前列腺肿瘤的监测。方法:采用A6 Fr. 20MHz导管放射扫描探头,未经麻醉等任何准备行TRUS。将5000个RM-9细胞(Dr.Thompson提供)接种到12周龄C57/B6雄性小鼠的前列腺背侧,引发原位肿瘤。第3 ~ 21天用TRUS监测肿瘤生长情况。此外,采用TRUS检测腹腔注射顺式二胺二氯铂(CDDP)后肿瘤生长抑制情况。结果:肿瘤细胞接种后7 d超声可检出肿瘤。TRUS图像清晰,与实际肿瘤生长平行。TRUS计算出的估计肿瘤体积(X)与尸检时测量的实际肿瘤重量(Y)显著相关;Y=101.653+ 1.174x (r =0.930, p <0.001)。同样,CDDP诱导的肿瘤生长抑制也被清楚地检测到,并且具有合理的准确性。结论:高分辨率TRUS可以简单可靠地监测原位肿瘤生长和生长抑制,使小鼠原位前列腺肿瘤模型更有效。
英文摘要
The mouse orthotopic prostate tumor model has been recognized as an ideal preclinical animal model simulating the anatomical and biological milieu of the prostate. In comparison with the subcutaneous tumor model, the only disadvantage of this model is the difficulty of chronological tumor growth monitoring. We have applied the resent endoluminal ultrasound technology, transrectal ultrasonography (TRUS), to monitoring of mouse orthotopic prostate tumors.METHODS : A6 Fr. 20MHz catheter-based radial scan probe was used and TRUS was performed without any prior preparation including anesthesia. Orthotopic tumors were initiated by inoculation of 5000 RM-9 cells (provided by Dr.Thompson) into the dorsal prostate of 12-week-old C57/B6 male mice. The tumor growth was monitored by TRUS from Day 3 to Day 21. In addition, TRUS was performed to detect tumor growth suppression after intraperitoneal administration of cis-diamminedichloroplatinum (CDDP).RESULTS : Ultrasonically, tumors became detectable 7 days after tumor cell inoculation. TRUS images were clear and parallel to actual tumor growth. The estimated tumor volume (X) calculated by TRUS correlated significantly with the actual tumor weight (Y) measured at autopsy ; Y=101.653+1.174X (R=0.930, P<0.001). Similarly, tumor growth suppression induced by CDDP was clearly detected with reasonable accuracy.CONCLUSIONS : A high resolution TRUS allows simple and reliable monitoring of in situ tumor growth and growth suppression, making the mouse orthotopic prostate tumor model more efficient.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Y,Nasu: "Diagnosis ans Treatment of Prostate Cancer - Recent Trend in Research - V.Gene Therapy"NIPPON RINSHO. 58. 299-302 (2000)
Y,Nasu:“前列腺癌的诊断和治疗 - 研究的最新趋势 - V.基因治疗”NIPPON RINSHO。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
日下信行: "Detection and monitoring of mouse orthotopic prostate tumor by transrectal ultrasound"The Prostate. (in press).
Nobuyuki Kusaka:“通过直肠超声检测和监测小鼠原位前列腺肿瘤”前列腺(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
那須保友: "前立腺の遺伝子治療"臨床と研究. 77(3). 536-540 (2000)
Yasutomo Nasu:“前列腺基因治疗”临床与研究77(3)536-540(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
那須保友: "Experimantal gene therapy for prostate cancer with adenovirus mediated interleukin-12 gene transduction alone and in combination with herpes simplex virus thymidine kinase gene transduction and ganciclovir therapy"Prostate Cancer and Prostate Disea
Nasu Yasutomo Nasu:“单独使用腺病毒介导的白细胞介素 12 基因转导以及与单纯疱疹病毒胸苷激酶基因转导和更昔洛韦疗法联合治疗前列腺癌的实验性基因疗法”前列腺癌和前列腺疾病
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    A novel therapeutic strategy for prostate cancer treatment with anti-cancer immunological proteins.
    • 批准号:
      24390368
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.57万
    • 财政年份:
      2012
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Basic and developmental research of a novel anti-tumor protein with dendritic cell-inducible activity.
    • 批准号:
      21390441
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2009
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Fundamental research for new molecular mechanism of anticancer resistance in urogenital cancer
    • 批准号:
      18390437
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.04万
    • 财政年份:
      2006
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    Research on Functional Analysis and Clinical application of New Tumor-associated Gene (REIC) in Urogenital Cancer
    • 批准号:
      15390491
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.43万
    • 财政年份:
      2003
    • 负责人:
      NASU Yasutomo
    • 依托单位:
    海外基金